Cell Growth & Differentiation, Vol 8, Issue 12 1287-1295, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential

R Irby, W Mao, D Coppola, R Jove, A Gamero, D Cuthbertson, DJ Fujita and TJ Yeatman
Department of Surgery, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, Florida 33612, USA.

Whereas genetic paradigms are now defined for the development of human colon cancer, little is known regarding the mechanisms that regulate development of the metastatic phenotype. Recent reports have indirectly linked the expression and activation of c-Src to the process of human colon cancer metastasis. Whereas v-Src, a highly activated mutational derivative of c-Src, has been shown to induce metastasis, normal c-Src has not been tested for this property. We hypothesized that c-Src overexpression in the milieu of a poorly metastatic cancer cell might permit the development of a highly metastatic cell. Two poorly metastatic human colon cancer cell lines were stably transfected with expression vectors encoding normal human c-Src. Clones producing 4-10-fold more c-Src than controls were injected s.c. and intrasplenically into the nude mouse to assess primary tumor growth and liver metastatic potential. Whereas metastatic potential was unaffected, primary tumor growth in vivo was significantly enhanced by c-Src overexpression. No effects on rates of tumor cell proliferation were seen in vitro. Our findings suggest that normal c-Src may be necessary but is insufficient for the induction of the metastatic phenotype.

This article has been cited by other articles:

				C. Oneyama, T. Hikita, S. Nada, and M. Okada Functional dissection of transformation by c-Src and v-Src. Genes Cells, January 1, 2008; 13(1): 1 - 12. [Abstract] [Full Text] [PDF]

				S. Zhu, J. D. Bjorge, and D. J. Fujita PTP1B Contributes to the Oncogenic Properties of Colon Cancer Cells through Src Activation Cancer Res., November 1, 2007; 67(21): 10129 - 10137. [Abstract] [Full Text] [PDF]

				S. Huveneers, I. van den Bout, P. Sonneveld, A. Sancho, A. Sonnenberg, and E. H.J. Danen Integrin {alpha}v{beta}3 Controls Activity and Oncogenic Potential of Primed c-Src Cancer Res., March 15, 2007; 67(6): 2693 - 2700. [Abstract] [Full Text] [PDF]

				A. Serrels, I. R.J. Macpherson, T.R. J. Evans, F. Y. Lee, E. A. Clark, O. J. Sansom, G. H. Ashton, M. C. Frame, and V. G. Brunton Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib Mol. Cancer Ther., December 1, 2006; 5(12): 3014 - 3022. [Abstract] [Full Text] [PDF]

				A. M. L. Coluccia, D. Benati, H. Dekhil, A. De Filippo, C. Lan, and C. Gambacorti-Passerini SKI-606 Decreases Growth and Motility of Colorectal Cancer Cells by Preventing pp60(c-Src)-Dependent Tyrosine Phosphorylation of {beta}-Catenin and Its Nuclear Signaling Cancer Res., February 15, 2006; 66(4): 2279 - 2286. [Abstract] [Full Text] [PDF]

				B. Olszewska-Pazdrak, C. M. Townsend Jr., and M. R. Hellmich Agonist-independent Activation of Src Tyrosine Kinase by a Cholecystokinin-2 (CCK2) Receptor Splice Variant J. Biol. Chem., September 24, 2004; 279(39): 40400 - 40404. [Abstract] [Full Text] [PDF]

				V. M. Golubovskaya, S. Gross, A. S. Kaur, R. I. Wilson, L.-H. Xu, X. H. Yang, and W. G. Cance Simultaneous Inhibition of Focal Adhesion Kinase and Src Enhances Detachment and Apoptosis in Colon Cancer Cell Lines Mol. Cancer Res., August 1, 2003; 1(10): 755 - 764. [Abstract] [Full Text] [PDF]